Vnitr Lek 1996, 42(7):451-453
[Recombinant interferon alfa in the treatment of essential thrombocythemia].
- Oddelenie klinickej hematológie FNsP, Kosice.
Klíčová slova: Adult; Female; Humans; Interferon Type I, therapeutic use, ; Male; Middle Aged; Recombinant Proteins; Thrombocytosis, therapy,
Essential thrombocythaemia, a clonal myeloproliferative disease characterized by a persisting increase of the number of thrombocytes, their abnormal morphology and function, is a special clinical and therapeutic problem which calls for a comprehensive approach. Based on a group of their own patients and on data from the literature, the authors discuss the asset of interferon alpha in the treatment of essential thrombocythaemia.
Keywords: Adult; Female; Humans; Interferon Type I /therapeutic use/; Male; Middle Aged; Recombinant Proteins; Thrombocytosis /therapy/
Zveřejněno: 1. červenec 1996 Zobrazit citaci